Management of cardiovascular complications secondary to medical treatment of cancer
As the prognoses of both heart and cancer patients have improved along with a longer life expectancy in the general population, the prevalence of both heart- and cancer diseases is increasing. Thus, a larger proportion of cancer patients will have cardiovascular co-morbidity and an increased risk of cardiovascular complications during and after cancer treatment. In this article, the current knowledge on the prevention, monitoring and treatment of cardiotoxicity induced by medical anti-cancer treatment with focus on anthracyclines, trastuzumab and 5-fluorouracil is described.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:180 |
|---|---|
| Enthalten in: |
Ugeskrift for laeger - 180(2018), 7 vom: 12. Feb. |
| Sprache: |
Dänisch |
|---|
| Beteiligte Personen: |
Banke, Ann [VerfasserIn] |
|---|
| Themen: |
Anthracyclines |
|---|
| Anmerkungen: |
Date Completed 15.03.2019 Date Revised 15.03.2019 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM281234167 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM281234167 | ||
| 003 | DE-627 | ||
| 005 | 20231225031149.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||dan c | ||
| 028 | 5 | 2 | |a pubmed24n0937.xml |
| 035 | |a (DE-627)NLM281234167 | ||
| 035 | |a (NLM)29465031 | ||
| 035 | |a (PII)V04170269 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a dan | ||
| 100 | 1 | |a Banke, Ann |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of cardiovascular complications secondary to medical treatment of cancer |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.03.2019 | ||
| 500 | |a Date Revised 15.03.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a As the prognoses of both heart and cancer patients have improved along with a longer life expectancy in the general population, the prevalence of both heart- and cancer diseases is increasing. Thus, a larger proportion of cancer patients will have cardiovascular co-morbidity and an increased risk of cardiovascular complications during and after cancer treatment. In this article, the current knowledge on the prevention, monitoring and treatment of cardiotoxicity induced by medical anti-cancer treatment with focus on anthracyclines, trastuzumab and 5-fluorouracil is described | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Anthracyclines |2 NLM | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Trastuzumab |2 NLM | |
| 650 | 7 | |a P188ANX8CK |2 NLM | |
| 650 | 7 | |a Fluorouracil |2 NLM | |
| 650 | 7 | |a U3P01618RT |2 NLM | |
| 700 | 1 | |a Polk, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Nielsen, Dorte |e verfasserin |4 aut | |
| 700 | 1 | |a Videbæk, Lars |e verfasserin |4 aut | |
| 700 | 1 | |a Overgaard, Ulrik |e verfasserin |4 aut | |
| 700 | 1 | |a Fosbøl, Emil Loldrup |e verfasserin |4 aut | |
| 700 | 1 | |a Vaage-Nielsen, Merete |e verfasserin |4 aut | |
| 700 | 1 | |a Nielsen, Kirsten Melgaard |e verfasserin |4 aut | |
| 700 | 1 | |a Schou, Morten |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Ugeskrift for laeger |d 1945 |g 180(2018), 7 vom: 12. Feb. |w (DE-627)NLM000011185 |x 1603-6824 |7 nnns |
| 773 | 1 | 8 | |g volume:180 |g year:2018 |g number:7 |g day:12 |g month:02 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 180 |j 2018 |e 7 |b 12 |c 02 | ||